Chairman of the Board, Interim President and CEO
Ms. Vered Caplan serves as Chairman of the Board, Chief Executive Officer, President of the Company and Chief Executive Officer of Orgenesis Maryland Inc, a subsidiary of the Company. Vered Caplan was appointed President and CEO on August 14, 2014, prior to which she was Interim President and CEO since December 23, 2013. Since 2008, Ms. Caplan was Chief Executive Officer of Kamedis, a company focused on utilizing plant extracts for dermatology purposes. From 2004 to 2007, Ms. Caplan was Chief Executive Officer of GammaCan, a company focused on the use of immunoglobulins for treatment of cancer. During the previous five years, Ms. Caplan was a director of the following companies Opticul Ltd., a company involved with optic based bacteria classification Inmotion Ltd., a company involved with selfpropelled disposable colonoscopies Nehora Photonics Ltd., a company involved with noninvasive blood monitoring Ocure Ltd., a company involved with wound management Eve Medical Ltd., a company involved with hormone therapy for Menopause and PMS and Biotech Investment Corporationration, a company involved with prostate cancer diagnostics
Age: 45 Chairman Since 2016Caplan has a M.Sc. in biomedical engineering from TelAviv University specializing in signal processing; management for engineers from TelAviv University specializing in business development; and a B.Sc. in mechanical engineering from the Technion specialized in software and cad systems.